Skip to main content
SpringerLink
Log in

Primary sclerosing cholangitis as an autoimmune disease: pros and cons

  • Chapter
Immunology and Liver

Part of the book series: Falk Symposium ((FASS,volume 114))

Abstract

Primary sclerosing cholangitis (PSC) is a disease of the intrahepatic and/or extrahepatic bile ducts which is characterized by concentric obliterative fibrosis and bile duct strictures eventually leading to biliary cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology. 1980;1980:200–206.

    Google Scholar 

  2. Chapman RWG, Arborgh BAM, Rhodes JM et al. Primary sclerosing cholangitis; a review of its clinical features, cholangiography and hepatic histology. Gut. 1980;21:870–877.

    Article  PubMed  CAS  Google Scholar 

  3. Broomé U, Olsson R, Lööf L et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610–615.

    Article  PubMed  Google Scholar 

  4. Escorsell A, Pares A, Rodés J, Soli-Herruzo J, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. J Hepatol. 1994;21:787–791.

    Article  PubMed  CAS  Google Scholar 

  5. Okolicsanyi L, Fabris L, Viaggi S et al. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables. An Italian multicenter study. Eur J Gastroenterol Hepatol. 1996;8:686–691.

    Google Scholar 

  6. Van Erpecum KM, Smits SJ, Van de Meeberg PC et al Risk of primary sclerosing cholangitis is associated with nonsmoking behaviour (see comments). Gastroenterology. 1996; 110(5): 1503–1506.

    Article  PubMed  Google Scholar 

  7. Loftus EVJ, Sandborn WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ. Primary sclerosing is associated with nonsmoking a case-control study (see comments). Gastroenterology. 1996;110(5):1496–1502.

    Article  PubMed  Google Scholar 

  8. Ludwig J, Barham SS, La Russo NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology. 1981;1:632–640.

    Article  PubMed  CAS  Google Scholar 

  9. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology. 1991; 129–133.

    Google Scholar 

  10. Farrant JM, Doherty DG, Donaldson PT et al Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology. 1992; 16(2): 390–395.

    Article  PubMed  CAS  Google Scholar 

  11. Olerup O, Olsson R, Hultcrantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology. 1995;108(3):870–878.

    Article  PubMed  CAS  Google Scholar 

  12. Mehal WZ, Lo YM, Wordsworth BP et al HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology. 1994; 106(1): 160–167.

    PubMed  CAS  Google Scholar 

  13. Spurkland A, Saarinen S, Bopberg KM et al HLA Class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens. 1999;53(5):459–469.

    Article  PubMed  CAS  Google Scholar 

  14. Aguilar HI, Nuako K, Krom RAF, Wiesner RH. Do primary sclerosing cholangitis (PSC) patients who express HLA-DR4 haplotype have a more rapidly progressive disease? (abstract). Hepatology. 1994;20:154A.

    Google Scholar 

  15. Moloney MM, Donaldson PT, Thomson LJ, Williams R. HLA-DR4 and DR4 subtypes confer resistance to primary sclerosing cholangitis and are not associated with poor prognosis (abstract). Hepatology. 1996;24:169A.

    Google Scholar 

  16. Bernal W, Maloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol. 1999;30:237–241.

    Article  PubMed  CAS  Google Scholar 

  17. Mitchell SA, Grove J, Spurkland A et al Association of the TNF A-308 but not the interleukin 10, 592 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut. 2000;(in press).

    Google Scholar 

  18. Duerr RH, Targan SR, Landers CJ et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1991; 100(5 pt 1): 1385–1391.

    PubMed  CAS  Google Scholar 

  19. Lo SK, Fleming KA, Chapman RW. Prevalence of anti-neutrophil antibodies in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut. 1992;33(10): 1370–1375.

    Article  PubMed  CAS  Google Scholar 

  20. Terjung B, Herzog V, Worman HJ et al. Atypical antineutrophil antibodies with perinuclear fluorescence in chronic inflammatory bowel disease and the hepatobiliary disorders colocalize with nuclear envelope lamina proteins. Hepatology. 1998;28:332–340.

    Article  PubMed  CAS  Google Scholar 

  21. Lo SK, Fleming KA, Chapman RW. A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. J Hepatol. 1994;21(6):974–978.

    Article  PubMed  CAS  Google Scholar 

  22. Broome U, Grunwald J, Scheynius A et al. Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis. J Hepatol. 1997;26:527–534.

    Article  PubMed  CAS  Google Scholar 

  23. Probert CS, Christ AD, Saubermann LJ et al. Analysis of human common bile duct-associated T cells: evidence of oligoclonality, T cell clonal persistence, and epithelial cell recognition. J Immunol. 1997;158:1941–1948.

    PubMed  CAS  Google Scholar 

  24. Chapman RW, Kelly PM, Heryet A, Jewell DP, Fleming KA. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut. 1988;29(4):422–427.

    Article  PubMed  CAS  Google Scholar 

  25. Bloom S, Fleming K, Chapman R. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut. 1995;36(4):604–609.

    Article  PubMed  CAS  Google Scholar 

  26. Spengler U, Leifeld L, Braunschweigeer I et al. Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J Hepatol. 1997;26:31–36.

    Article  PubMed  CAS  Google Scholar 

  27. Broomé U, Hultcrantz R, Scheynius A. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis. Scand J Gastroenterol. 1993;28(2): 126–130.

    Article  PubMed  Google Scholar 

  28. Vierling J. Aetiopathogenesis of primary sclerosing cholangitis. In: Manns M, Chapman RW, Stiehl A, Wiesner R, Eds. Primary Sclerosing Cholangitis. London: Kluwer Academic Publishers, 1998:37–45.

    Google Scholar 

Download references

Authors
  1. R. W. Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abt. Gastroenterologie/Hepatologie Zentrum Innere Medizin, Medizinische Hochscule Hannover, Carl-Neuberg Str. 1, D-30625, Hannover, Germany

    M. P. Manns

  2. Medizinische Klinik II, Klinikum Grosshadern der LMU München, Marchioninistr. 15, D-81377, München, Germany

    G. Paumgartner

  3. Abt. Gastroenterologie Zentrum der Innere Medizin, Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, D-60596, Frankfurt, Germany

    U. Leuschner

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Chapman, R.W. (2000). Primary sclerosing cholangitis as an autoimmune disease: pros and cons. In: Manns, M.P., Paumgartner, G., Leuschner, U. (eds) Immunology and Liver. Falk Symposium, vol 114. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4000-3_24

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4000-3_24

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5768-4

  • Online ISBN: 978-94-011-4000-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation